NEW YORK, Dec. 1 Reportlinker.com announces that a new market research report is available in its catalogue:
The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Advertisement
http://www.reportlinker.com/p0166814/The-Future-of-Central-Nervous-System-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html
Advertisement
Summary
The author has released its latest research "The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis." The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global CNS diseases therapeutics market. The report analyzes the markets for CNS disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
Scope
The scope of this report includes:
- Annualized market data for the CNS diseases therapeutics market from 2000 to 2008, forecast forward to 2015
- Analysis of the leading therapeutic segments including Alzheimer's disease, Parkinson's disease, Schizophrenia and Bipolar Disorder, Epilepsy, Major depressive disorder (MDD), anxiety and panic disorder, Attention Deficit Hyperactivity Disorder (ADHD) and Insomnia.
- Analysis of the CNS diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the CNS diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, Novartis AG, Sanofi-aventis, Lundbeck A/S, AstraZeneca, Merck & Co, Pfizer Inc, UCB S.A., Bristol-Myers Squibb and Eli Lilly
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global CNS diseases therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 9
1.2 List of Figures 15
2 Global CNS Therapeutics Market : Introduction 20
2.1 Disease Overview 20
2.2 GBI Research Report Guidance 20
3 Global CNS Therapeutics Market: Market Characterization 22
3.1 Market Overview 22
3.2 Market Forecasts 24
3.3 Branded Versus Generics 25
3.4 Market Share by Disease Sectors 26
3.5 Average Cost of Therapy 26
3.6 Volume 28
3.7 Usage Patterns 29
3.7.1 Diseased Population 29
3.7.2 Treatment Seeking Population 30
3.7.3 Diagnosis Population 31
3.7.4 Prescription Population 32
3.7.5 Therapeutic Usage Patterns 33
3.8 Geographical Distribution 34
3.9 Market Drivers and Restraints 36
3.9.1 Market Drivers 36
3.9.2 Market Restraints 37
3.10 Unmet Needs 39
3.10.1 Alzheimer's Disease 40
3.10.2 Parkinson's Disease 40
3.10.3 Schizophrenia and bipolar Disorder 40
3.10.4 Depression 40
3.10.5 Insomnia 40
3.11 Key Market Trends 41
3.11.1 Increase in Disease Incidence and Prevalence Rates 41
3.11.2 Product Pipeline 41
3.11.3 Advertising and Commercialization 42
3.11.4 Regulatory trends - Current Reimbursement Scenario 42
4 Global Alzheimer's Disease Therapeutics Market 44
4.1 Market Overview 44
4.2 Market Forecasts 44
4.3 Average Cost of Therapy 45
4.4 Volume 46
4.5 Usage Patterns 48
4.5.1 Diseased Population 48
4.5.2 Treatment Seeking Population 49
4.5.3 Diagnosis Population 50
4.5.4 Prescription Population 51
4.5.5 Therapeutic Usage Patterns 52
4.6 Product Analysis 53
4.6.1 Aricept 53
4.6.2 Exelon and Exelon Patch 54
4.6.3 Ebixa (Namenda) 55
4.6.4 Razadyne and Reminyl 55
4.7 Drug Pipeline Analysis 55
5 Global Parkinson's Disease Therapeutics Market 59
5.1 Market Overview 59
5.2 Market Forecasts 59
5.3 Average Cost of Therapy 61
5.4 Volume 62
5.5 Usage Patterns 63
5.5.1 Diseased Population 63
5.5.2 Treatment Seeking Population 64
5.5.3 Diagnosis Population 65
5.5.4 Prescription Population 66
5.5.5 Therapeutic Usage Patterns 67
5.6 Product Analysis 68
5.6.1 Azilect 68
5.6.2 Stalevo/Comtan 69
5.6.3 Madopar 69
5.6.4 Neupro 69
5.6.5 Requip/Requip XL 70
5.6.6 Sifrol/Mirapex 70
5.6.7 Sinemet 70
5.7 Drug Pipeline Analysis 70
6 Global Schizophrenia and Bipolar Disorder Therapeutics Market 73
6.1 Market Overview 73
6.2 Market Forecasts 73
6.3 Average Cost of Therapy 75
6.4 Volume 76
6.5 Usage Patterns 77
6.5.1 Diseased Population 77
6.5.2 Treatment Seeking Population 78
6.5.3 Diagnosis Population 79
6.5.4 Prescription Population 80
6.5.5 Therapeutic Usage Patterns 81
6.6 Product Analysis 82
6.6.1 Abilify 82
6.6.2 Clozaril 83
6.6.3 Geodon/Zeldox 83
6.6.4 Invega 84
6.6.5 Risperdal/Risperdal Consta 85
6.6.6 Serdolect 85
6.6.7 Seroquel 85
6.6.8 Zyprexa 86
6.7 Drug Pipeline Analysis 86
7 Global Epilepsy Therapeutics Market 89
7.1 Market Overview 89
7.2 Market Forecasts 89
7.3 Average Cost of Therapy 90
7.4 Volume 91
7.5 Usage Patterns 92
7.5.1 Diseased Population 92
7.5.2 Treatment Seeking Population 93
7.5.3 Diagnosis Population 94
7.5.4 Prescription Population 95
7.5.5 Therapeutic Usage Patterns 96
7.6 Product Analysis 98
7.6.1 Depakine 98
7.6.2 Keppra/Keppra XR and Vimpat 98
7.6.3 Lamictal 99
7.6.4 Lyrica 100
7.6.5 Neurontin 100
7.6.6 Tegretol 100
7.6.7 Trileptal 100
7.6.8 Topamax 101
7.6.9 Vimpat 101
7.7 Drug Pipeline Analysis 101
8 Global MDD, Anxiety and Panic Disorder Therapeutics Market 103
8.1 Market Overview 103
8.2 Market Forecasts 103
8.3 Average Cost of Therapy 105
8.4 Volume 106
8.5 Usage Patterns 107
8.5.1 Diseased Population 107
8.5.2 Treatment Seeking Population 108
8.5.3 Diagnosis Population 109
8.5.4 Prescription Population 110
8.5.5 Therapeutic Usage Patterns 111
8.6 Product Analysis 112
8.6.1 Celexa 112
8.6.2 Cipralex 113
8.6.3 Cymbalta 113
8.6.4 Effexor 114
8.6.5 Lexapro 114
8.6.6 Pristiq 114
8.6.7 Seroxat/Paxil 114
8.6.8 Wellbutrin/Wellbutrin XL 115
8.6.9 Xanax 115
8.6.10 Zoloft 115
8.7 Drug Pipeline Analysis 115
9 Global ADHD Therapeutics Market 118
9.1 Market Overview 118
9.2 Market Forecasts 118
9.3 Average Cost of Therapy 120
9.4 Volume 121
9.5 Usage Patterns 121
9.5.1 Diseased Population 121
9.5.2 Treatment Seeking Population 122
9.5.3 Diagnosis Population 123
9.5.4 Prescription Population 124
9.5.5 Therapeutic Usage Patterns 125
9.6 Product Analysis 127
9.6.1 Adderall/Adderall XR 127
9.6.2 Concerta 127
9.6.3 Daytrana 127
9.6.4 Focalin/Retalin 128
9.6.5 Strattera 129
9.6.6 Vyvanse 129
9.7 Drug Pipeline Analysis 129
10 Global Insomnia Therapeutics Market 131
10.1 Market Overview 131
10.2 Market Forecasts 131
10.3 Average Cost of Therapy 133
10.4 Volume 134
10.5 Usage Patterns 135
10.5.1 Diseased Population 135
10.5.2 Treatment Seeking Population 136
10.5.3 Diagnosis Population 137
10.5.4 Prescription Population 138
10.5.5 Therapeutic Usage Patterns 138
10.6 Product Analysis 140
10.6.1 Halcion 140
10.6.2 Lunesta 140
10.6.3 Rozerem 141
10.6.4 Ambien/Stilnox/Ambien CR 141
10.6.5 Sonata 142
10.7 Drug Pipeline Analysis 142
11 Global CNS Therapeutics Market: The US Market 146
11.1 Market Overview 146
11.2 Market Forecasts 146
11.3 Average Cost of Therapy 148
11.4 Volume 149
11.5 Usage Patterns 149
11.5.1 Diseased Population 149
11.5.2 Treatment Seeking Population 151
11.5.3 Diagnosis Population 152
11.5.4 Prescription Population 153
11.5.5 Therapeutic Usage Patterns 154
12 Global CNS Therapeutics Market: The European Market 156
12.1 Market Overview 156
12.2 Market Forecasts 156
12.3 Average Cost of Therapy 157
12.4 Volume 158
12.5 Usage Patterns 159
12.5.1 Diseased Population 159
12.5.2 Treatment Seeking Population 160
12.5.3 Diagnosis Population 161
12.5.4 Prescription Population 162
12.5.5 Therapeutic Usage Patterns 163
13 Global CNS Therapeutics Market: The Japanese Market 165
13.1 Market Overview 165
13.2 Market Forecasts 165
13.3 Average Cost of Therapy 166
13.4 Volume 168
13.5 Usage Patterns 168
13.5.1 Diseased Population 168
13.5.2 Treatment Seeking Population 170
13.5.3 Diagnosis Population 170
13.5.4 Prescription Population 171
13.5.5 Therapeutic Usage Patterns 172
14 Global CNS Therapeutics Market: Competitive Landscape 175
14.1 Overview 175
14.2 Market Share Analysis 176
14.3 Competitive Profiling 178
14.3.1 AstraZeneca 179
14.3.2 Boehringer Ingelheim 179
14.3.3 Bristol-Myers Squibb 179
14.3.4 Eli Lilly 179
14.3.5 GlaxoSmithKline (GSK) 179
14.3.6 Johnson & Johnson 180
14.3.7 H. Lundbeck A/S 180
14.3.8 Novartis 180
14.3.9 Pfizer 181
14.3.10 Sanofi Aventis 181
14.3.11 Shire Pharmaceuticals 181
14.3.12 UCB Pharma 181
14.3.13 Wyeth 181
15 Global CNS Therapeutics Market: Strategic Consolidations 183
15.1 Mergers and Acquisitions 183
15.1.1 Overview 183
15.2 Licensing Agreements 185
15.2.1 Preclinical 187
15.2.2 Phase I 188
15.2.3 Phase II 189
15.2.4 Phase III 190
15.2.5 Approved 191
16 Global CNS Therapeutics Market : Appendix 193
16.1 Market Definitions 193
16.2 Abbreviations 193
16.3 Research Methodology 193
16.4 Coverage 194
16.5 Secondary Research 194
16.6 Primary Research 195
16.7 Models 195
16.8 Forecasts 195
16.8.1 Epidemiology-based Forecasting 195
16.9 Expert Panel Validation 197
16.10 Contact Us 198
16.11 Disclaimer 198
1.1 List of Tables
Table 1: CNS Therapeutics Market, Global, Revenues ($m), 2000-2008 24
Table 2: CNS Therapeutics Market, Global, Revenue Forecasts ($m), 2008-2015 24
Table 3: CNS Therapeutics Market, Global, Revenue Segmentation ($m), 2000-2008 25
Table 4: CNS Therapeutics Market, Global, Revenue Segmentation ($m), 2008-2015 26
Table 5: CNS Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($), 2000-2008 27
Table 6: CNS Therapeutics Market, Global, Forecasts for Average Cost of Therapy ($),
2008-2015 27
Table 7: CNS Therapeutics Market, Global, Historical Figures for Volume (000), 2000-2008 28
Table 8: CNS Therapeutics Market, Global, Forecasts for Volume, 2008-2015 28
Table 9: CNS Therapeutics Market, Global, Historical Figures for Diseased Population,
2000-2008 29
Table 10: CNS Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015 29
Table 11: CNS Therapeutics Market, Global, Historical Figures for Treatment Seeking Population, 2000-2008 30
Table 12: CNS Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015 30
Table 13: CNS Therapeutics Market, Global, Historical Figures for Diagnosis Population,
2000-2008 31
Table 14: CNS Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015 31
Table 15: CNS Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008 32
Table 16: CNS Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015 32
Table 17: CNS Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patterns, 2000-2008 33
Table 18: CNS Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns,
2008-2015 34
Table 19: CNS Therapeutics Market, Global, Market Drivers, 2008 36
Table 20: CNS Therapeutics Market, Global, Market Restraints, 2008 37
Table 21: CNS Therapeutics Market, Global, Major Drug Patent Expirations, 2008-2015 38
Table 22: CNS Therapeutics Market, Global, Reimbursement Policies of Various 43
Table 23: Alzheimer's Disease Therapeutics Market, Historical Revenue ($m), 2000-2008 45
Table 24: Alzheimer's Disease Therapeutics Market, Revenue Forecasts ($m), 2008-2015 45
Table 25: Alzheimer's Disease Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($), 2000-2008 46
Table 26: Alzheimer's Disease Therapeutics Market, Global, Forecasts for Average Cost of Therapy ($), 2008-2015 46
Table 27: Alzheimer's Disease Therapeutics Market, Global, Historical Figures for Volume, 2000-2008 47
Table 28: Alzheimer's Disease Therapeutics Market, Global, Historical Figures for Volume, 2008-2015 47
Table 29: Alzheimer's Disease Therapeutics Market, Global, Historical Figures for Diseased Population, 2000-2008 48
Table 30: Alzheimer's Disease Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015 49
Table 31: Alzheimer's Disease Therapeutics Market, Global, Historical Figures for Treatment Seeking Population, 2000-2008 49
Table 32: Alzheimer's Disease Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015 50
Table 33: Alzheimer's Disease Therapeutics Market, Global, Historical Figures for Diagnosis Population, 2000-2008 50
Table 34: Alzheimer's Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015 51
Table 35: Alzheimer's Disease Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008 51
Table 36: Alzheimer's Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015 52
Table 37: Alzheimer's Disease Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patterns, 2000-2008 53
Table 38: Alzheimer's Disease Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015 53
Table 39: Alzheimer's Disease Therapeutics Market, Global, Major Manufacturers and Drugs, 2008 53
Table 40: Alzheimer's Disease Therapeutics Market, Global, Clinical Trials Pipeline, 2008 56
Table 41: Parkinson's Disease Therapeutics Market, Global, Historical Revenues ($m),
2000-2008 60
Table 42: Parkinson's Disease Therapeutics Market, Global, Revenue Forecasts ($m),
2008-2015 61
Table 43: Parkinson's Disease Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($), 2000-2008 61
Table 44: Parkinson's Disease Therapeutics Market, Global, Forecasts for Average Cost of Therapy ($), 2008-2015 62
Table 45: Parkinson's Disease Therapeutics Market, Global, Historical Figures for Volume, 2000-2008 62
Table 46: Parkinson's Disease Therapeutics Market, Global, Forecasts for Volume, 2008-2015 63
Table 47: Parkinson's Disease Therapeutics Market, Global, Historical Figures for Diseased Population, 2000-2008 64
Table 48: Parkinson's Disease Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015 64
Table 49: Parkinson's Disease Therapeutics Market, Global, Historical Figures for Treatment Seeking Population, 2000-2008 65
Table 50: Parkinson's Disease Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015 65
Table 51: Parkinson's Disease Therapeutics Market, Global, Historical Figures for Diagnosis Population, 2000-2008 66
Table 52: Parkinson's Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015 66
Table 53: Parkinson's Disease Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008 67
Table 54: Parkinson's Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015 67
Table 55: Parkinson's Disease Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patterns, 2000-2008 68
Table 56: Parkinson's Disease Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015 68
Table 57: Parkinson's Disease Therapeutics Market, Global, Major Manufacturers and Drugs, 2008 68
Table 58: Parkinson's Disease Therapeutics Market, Global, Clinical Trials Pipeline, 2008 71
Table 59: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Revenues ($m), 2000-2008 74
Table 60: Schizophrenia and Bipolar Disorder Therapeutics Market, Global,, Revenue Forecasts ($m), 2008-2015 75
Table 61: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($), 2000-2008 76
Table 62: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Average Cost of Therapy ($), 2008-2015 76
Table 63: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Volume, 2000-2008 77
Table 64: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Volume, 2008-2015 77
Table 65: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Diseased Population, 2000-2008 78
Table 66: Schizophrenia and Bipolar Disorder Therapeutics Market, Forecasts for Diseased Population, 2008-2015 78
Table 67: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Treatment Seeking Population, 2000-2008 79
Table 68: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015 79
Table 69: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Diagnosis Population, 2000-2008 80
Table 70: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015 80
Table 71: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008 81
Table 72: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015 81
Table 73: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patterns, 2000-2008 82
Table 74: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015 82
Table 75: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Major Manufacturers and Drugs, 2008 83
Table 76: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Clinical Trials Drug Portfolio, 2008 86
Table 77: Epilepsy Therapeutics Market, Global, Historical Revenues ($m), 2000-2008 90
Table 78: Epilepsy Therapeutics Market, Global, Revenue Forecasts ($m), 2008-2015 90
Table 79: Epilepsy Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($), 2000-2008 91
Table 80: Epilepsy Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 91
Table 81: Epilepsy Therapeutics Market, Global, Historical Figures for Volume, 2000-2008 92
Table 82: Epilepsy Therapeutics Market, Global, Forecasts for Volume, 2008-2015 92
Table 83: Epilepsy Therapeutics Market, Global, Historical Figures for Diseased Population, 2000-2008 93
Table 84: Epilepsy Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015 93
Table 85: Epilepsy Therapeutics Market, Global, Historical Figures for Treatment Seeking Population, 2000-2008 94
Table 86: Epilepsy Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015 94
Table 87: Epilepsy Therapeutics Market, Global, Historical Figures for Diagnosis Population, 2000-2008 95
Table 88: Epilepsy Therapeutics Market, Global, Forecasts for Diagnosis Population,
2008-2015 95
Table 89: Epilepsy Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008 96
Table 90: Epilepsy Therapeutics Market, Forecasts for Prescription Population, 2008-2015 96
Table 91: Epilepsy Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patters, 2000-2008 97
Table 92: Epilepsy Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015 97
Table 93: Epilepsy Therapeutics Market, Global, Major Manufacturers and Drugs, 2008 98
Table 94: Epilepsy Therapeutics Market, Global, Clinical Trials Drug Portfolio, 2008 101
Table 95: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Revenues ($m), 2000-2008 104
Table 96: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Revenue Forecasts ($m), 2008-2015 104
Table 97: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Average Cost of Therapy ($), 2000-2008 105
Table 98: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Average Cost of Therapy ($), 2008-2015 105
Table 99: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Volume, 2000-2008 106
Table 100: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Volume, 2008-2015 106
Table 101: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Diseased Population, 2000-2008 107
Table 102: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Diseased Population, 2008-2015 108
Table 103: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historic Figures for Treatment Seeking Population, 2000-2008 108
Table 104: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2008-2015 109
Table 105: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Diagnosis Population, 2000-2008 109
Table 106: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Diagnosis Population, 2008-2015 110
Table 107: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Prescription Population, 2000-2008 110
Table 108: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Forecasts for Prescription Population, 2008-2015 111
Table 109: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Historical Figures for Therapeutic Usage Patterns, 2000-2008 112
Table 110: MDD, Anxiety Panic Disorder Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2008-2015 112
Table 111: MDD, Anxiety and Panic Disorder Therapeutics Market, Global, Major Manufacturers and Drugs, 2008 112
Table 112: Global MDD, Panic and Anxiety Disorder Therapeutics Market, Clinical Trials Drug Portfolio, 2008 115
Table 113: Global ADHD Therapeutics Market, Historical Revenues ($m), 2000-2008 119
Table 114: Global ADHD Therapeutics Market, Revenues Forecasts ($million), 2008-2015 119
Table 115: ADHD Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 120
Table 116: ADHD Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 120
Table 117: Global ADHD Therapeutics Market, Historical Figures for Volume, 2000-2008 121
Table 118: Global ADHD Therapeutics Market, Forecasts for Volume, 2008-2015 121
Table 119: Global ADHD Therapeutics Market, Historical Figures for Diseased Population,
2000-2008 122
Table 120: Global ADHD Therapeutics Market, Forecasts for Diseased Population, 2008-2015 122
Table 121: Global ADHD Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 123
Table 122: Global ADHD Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015 123
Table 123: Global ADHD Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 124
Table 124: Global ADHD Therapeutics Market, Forecasts for Diagnosis Population, 2008-2015 124
Table 125: Global ADHD Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 125
Table 126: Global ADHD Therapeutics Market, Forecasts for Prescription Population,
2008-2015 125
Table 127: Global ADHD Therapeutics Market, Historical Figures for Therapeutic Usage Patterns, 2000-2008 126
Table 128: Global ADHD Therapeutics Market, Forecasts for Therapeutic Usage Patterns,
2008-2015 126
Table 129: Global ADHD Therapeutics Market, Major Manufacturers and Drugs, 2008 127
Table 130: Global Insomnia Therapeutics Market, Historical Revenues ($m), 2000-2008 132
Table 131: Global Insomnia Therapeutics Market, Revenue Forecasts ($m), 2008-2015 132
Table 132: Global Insomnia Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008 133
Table 133: Global Insomnia Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015 133
Table 134: Insomnia Therapeutics Market, Historical Figures for Volume, 2000-2008 134
Table 135: Insomnia Therapeutics Market, Forecasts for Volume, 2008-2015 134
Table 136: Global Insomnia Therapeutics Market, Historical Figures for Diseased Population, 2000-2008 135
Table 137: Global Insomnia Therapeutics Market, Forecasts for Diseased Population,
2008-2015 135
Table 138: Global Insomnia Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008 136
Table 139: Insomnia Therapeutics Market, Forecasts for Treatment Seeking Population,
2008-2015 136
Table 140: Global Insomnia Therapeutics Market, Historical Figures for Diagnosis Population, 2000-2008 137
Table 141: Global Insomnia Therapeutics Market, Forecasts for Diagnosis Population,
2008-2015 137
Table 142: Global Insomnia Therapeutics Market, Historical Figures for Prescription Population, 2000-2008 138
Table 143: Global Insomnia Therapeutics Market, Forecasts for Prescription Population,
2008-2015 138
Table 144: Global Insomnia Therapeutics Market, Historical Figures for Therapeutic Usage Patterns, 2000-2008 139
Table 145: Global Insomnia Therapeutics Market, Forecasts for Therapeutic Usage Patterns, 2008-2015 139
Table 146: Global Insomnia Therapeutics Market, Major Manufacturers and Drugs, 2008 140
Table 147: Insomnia Therapeutics Market, Clinical Trials Pipeline, 2008 142
Table 148: CNS Therapeutics Market, US, Historical Revenues ($m), 2000-2008 147
Table 149: CNS Therapeutics Market, US, Revenue Forecasts ($m), 2008-2015 147
Table 150: CNS Therapeutics Market, US, Historical Figures for the Average Cost of Therapy ($), 2000-2008 148
Table 151: CNS Therapeutics Market, US, Forecasts for the Average Cost of Therapy ($),
2008-2015 148
Table 152: CNS Therapeutics Market, US, Historical Figures for Volume, 2000-2008 149
Table 153: CNS Therapeutics Market, US, Forecasts for Volume, 2008-2015 149
Table 154: CNS Therapeutics Market, US, Historical Figures for Diseased Population,
2000-2008 150
Table 155: CNS Therapeutics Market, US, Forecasts for Diseased Population, 2008-2015 151
Table 156: CNS Therapeutics Market, US, Historical Figures for Treatment Seeking Population, 2000-2008 151
Table 157: CNS Therapeutics Market, US, Forecasts for Treatment Seeking Population,
2008-2015 152
Table 158: CNS Therapeutics Market, US, Historical Figures for Diagnosis Population,
2000-2008 153
Table 159: CNS Therapeutics Market, US, Forecasts for Diagnosis Population, 2008-2015 153
Table 160: CNS Therapeutics Market, US, Historical Figures for Prescription Population,
2000-2008 154
Table 161: CNS Therapeutics Market, US, Forecasts for Prescription Population, 2008-2015 154
Table 162: CNS Therapeutics Market, US, Historical Figures for Usage Patterns, 2000-2008 155
Table 163: CNS Therapeutics Market, US, Forecasts for Usage Patterns, 2008-2015 155
Table 164: CNS Therapeutics Market, Europe, Historical Revenues ($m), 2000-2008 157
Table 165: CNS Therapeutics Market, Europe, Revenue Forecasts ($m), 2008-2015 157
Table 166: CNS Therapeutics Market, Europe, Historical Figures for Average Cost of Treatment, 2000-2008 158
Table 167: CNS Therapeutics Market, Europe, Forecasts for Average Cost of Treatment,
2008-2015 158
Table 168: CNS Therapeutics Market, Europe, Historical Figures for Volume, 2000-2008 159
Table 169: CNS Therapeutics Market, Europe, Forecasts for Volume, 2008-2015 159
Table 170: CNS Therapeutics Market, Europe, Historical Figures for Diseased Population,
2000-2008 160
Table 171: CNS Therapeutics Market, Europe, Forecasts for Diseased Population, 2008-2015 160
Table 172: CNS Therapeutics Market, Europe, Historical Figures for Treatment Seeking Population, 2000-2008 161
Table 173: CNS Therapeutics Market, Europe, Forecasts for Treatment Seeking Population, 2008-2015 161
Table 174: CNS Therapeutics Market, Europe, Historical Figures for Diagnosis Population, 2000-2008 162
Table 175: CNS Therapeutics Market, Europe, Forecasts for Diagnosis Population, 2008-2015 162
Table 176: CNS Therapeutics Market, Europe, Historical Figures for Prescription Population, 2000-2008 163
Table 177: CNS Therapeutics Market, Europe, Forecasts for Prescription Population, 2008-2015 163
Table 178: CNS Therapeutics Market, Europe, Historical Figures for Therapeutic Usage Patterns, 2000-2008 164
Table 179: CNS Therapeutics Market, Europe, Forecasts for Therapeutic Usage Patterns,
2008-2015 164
Table 180: CNS Therapeutics Market, Japan, Historical Revenues ($m), 2000-2008 166
Table 181: CNS Therapeutics Market, Japan, Revenue Forecasts ($m), 2008-2015 166
Table 182: CNS Therapeutics Market, Japan, Historical Figures for Average Cost of Therapy ($), 2000-2008 167
Table 183: CNS Therapeutics Market, Japan, Forecasts for Average Cost of Therapy ($),
2008-2015 167
Table 184: CNS Therapeutics Market, Japan, Historical Figures for Volume, 2000-2008 168
Table 185: CNS Therapeutics Market, Japan, Forecasts for Volume, 2008-2015 168
Table 186: CNS Therapeutics Market, Japan, Historical Figures for Diseased Population,
2000-2008 169
Table 187: CNS Therapeutics Market, Japan, Forecasts for Diseased Population, 2008-2015 169
Table 188: CNS Therapeutics Market, Japan, Historical Figures for Treatment Seeking Population, 2000-2008 170
Table 189: CNS Therapeutics Market, Japan, Forecasts for Treatment Seeking Population, 2008-2015 170
Table 190: CNS Therapeutics Market, Japan, Historical Figures for Diagnosis Population,
2000-2008 171
Table 191: CNS Therapeutics Market, Japan, Forecasts for Diagnosis Population, 2008-2015 171
Table 192: CNS Therapeutics Market, Japan, Historical Figures for Prescription Population, 2000-2008 172
Table 193: CNS Therapeutics Market, Japan, Forecasts for Prescription Population, 2008-2015 172
Table 194: CNS Therapeutics Market, Japan, Historical Figures for Therapeutic Usage Patterns, 2000-2008 173
Table 195: CNS Therapeutics Market, Japan, Forecasts for Therapeutic Usage Patterns,
2008-2015 174
Table 196: CNS Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical Stage, 2008 187
Table 197: CNS Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I Stage, 2008 188
Table 198: CNS Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase II Stage, 2008 189
Table 199: CNS Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase III Stage, 2008 190
Table 200: CNS Therapeutics Market, Global, Licensing Agreements for Approved Drugs, 2008 191
1.2 List of Figures
Figure 1: CNS Therapeutics Market, Global, Market Overview, 2008 22
Figure 2: CNS Therapeutics Market, Global, Key Geographical Trends, 2008 23
Figure 3: CNS Therapeutics Market, Global, Revenue Forecasts ($bn), 2000-2015 24
Figure 4: CNS Therapeutics Market, Global, Revenue Split ($bn), 2000-2015 25
Figure 5: CNS Therapeutics Market, Global, Market Share of Major Disease Sectors, 2008 26
Figure 6: Global CNS Therapeutics Market, Average Cost of Therapy ($), 2000-2015 27
Figure 7: CNS Therapeutics Market, Global, Forecasts for Volume, 2000-2015 28
Figure 8: CNS Therapeutics Market, Global, Forecasts for Diseased Population, 2000-2015 29
Figure 9: CNS Therapeutics Market, Global, Forecasts for Treatment Seeking Population,
2000-2015 30
Figure 10: CNS Therapeutics Market, Global, Forecasts for Diagnosis Population, 2000-2015 31
Figure 11: CNS Therapeutics Market, Global, Forecasts for Prescription Population, 2000-2015 32
Figure 12: CNS Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns,
2000-2015 33
Figure 13: CNS Therapeutics Market, Global, Geographical Distribution of Revenues ($bn), 2000-2015 34
Figure 14: CNS Therapeutics Market, Global, Geographical Comparison of Market Competition, 2008 35
Figure 15: CNS Therapeutics Market, Global, Market Indicators, 2008 36
Figure 16: CNS Therapeutics Market, Global, Analysis of Unmet Needs for Major Disease Sectors, 2008 39
Figure 17: CNS Therapeutics Market, Global, Key Market Events, 2008-2015 41
Figure 18: Alzheimer's Disease Therapeutics Market, Global, Revenue Forecasts ($m),
2000-2015 44
Figure 19: Alzheimer's Disease Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015 46
Figure 20: Alzheimer's Disease Therapeutics Market, Global, Global, Forecasts for Volume, 2000-2015 47
Figure 21: Alzheimer's Disease Therapeutics Market, Global, Forecasts for Diseased Population, 2000-2015 48
Figure 22: Alzheimer's Disease Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2000-2015 49
Figure 23: Alzheimer's Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2000-2015 50
Figure 24: Alzheimer's Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2000-2015 51
Figure 25: Alzheimer's Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2000-2015 52
Figure 26: Alzheimer's Disease Therapeutics Market, Global, Market Share of Major Therapeutic Drugs, 2008 54
Figure 27: Alzheimer's Disease Therapeutics Market, Global, Historical Revenues of Major Drugs ($m), 2006-2008 55
Figure 28: Alzheimer's Disease Therapeutics Market, Global, Share Assessment of Molecules Under Stages of Clinical Development, 2008 57
Figure 29: Alzheimer's Disease Therapeutics Market, Global, Clinical Trials Drug Portfolio, 2008 57
Figure 30: Alzheimer's Disease Therapeutics Market, Global, Major Manufacturers and their Pipeline Portfolio, 2008 58
Figure 31: Parkinson's Disease Therapeutics Market, Global, Revenue Forecasts ($m),
2000-2015 60
Figure 32: Parkinson's Disease Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015 61
Figure 33: Parkinson's Disease Therapeutics Market, Global, Forecasts for Volume, 2000-2015 62
Figure 34: Parkinson's Disease Therapeutics Market, Global, Forecasts for Diseased Population, 2000-2015 63
Figure 35: Parkinson's Disease Therapeutics Market, Global, Forecasts for Treatment Seeking Population, 2000-2015 64
Figure 36: Parkinson's Disease Therapeutics Market, Global, Forecasts for Diagnosis Population, 2000-2015 65
Figure 37: Parkinson's Disease Therapeutics Market, Global, Forecasts for Prescription Population, 2000-2015 66
Figure 38: Parkinson's Disease Therapeutics Market, Global, Forecasts for Therapeutic Usage Patterns, 2000-2015 67
Figure 39: Parkinson's Disease Therapeutics Market, Global, Market Share of Major Therapeutic Drugs, 2008 69
Figure 40: Parkinson's Disease Therapeutics Market, Global, Historic Revenues of Major Drugs ($m), 2006-2008 70
Figure 41: Parkinson's Disease Therapeutics Market, Global, Share Assessment of Molecules Under Stages of Development, 2008 71
Figure 42: Parkinson's Disease Therapeutics Market, Global, Clinical Trials Drug Portfolio, 2008 72
Figure 43: Parkinson's Disease Therapeutics Market, Global, Major Manufacturers and their Pipeline Portfolio, 2008 72
Figure 44: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Revenue Forecasts ($m), 2000-2015 74
Figure 45: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015 75
Figure 46: Schizophrenia and Bipolar Disorder Therapeutics Markets, Global, Forecasts for Volume, 2000-2015 76
Figure 47: Schizophrenia and Bipolar Disorder Therapeutics Market, Global, Forecasts for Diseased Population, 2000-2015 77
Figure 48: Schizophrenia and Bipolar Disorder Therapeutics Market, Glob
To order this report:
Therapy Industry: The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
More Market Research Report
Nicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
